Jonathan is a neuroscientist and medical doctor based at University College London with ties to King's College, and the president and founder of the UCL Society for the Application of Psychedelics.
His research focuses on the use of psychedelic compounds, like LSD and psilocybin - the active ingredient in magic mushrooms - in the treatment of mental health disorders. This will include the treatment of a large number of patients for depression with psilocybin in a clinical trial over the next 4 years. He has worked with prominent figures in the field, including writing a comprehensive review with Professor David Nutt.
Jonathan is in his element talking about taboo subjects such as psychedelic drugs, mental health and madness. He believes that in our modern, comfortable world our greatest pains are mental - what a buddhist might suitably call 'suffering'. His mission is to stoke conversation about mental health, change attitudes that still persist in even the most tolerant parts of our society, and encourage innovation like the use of psychedelic drugs to help improve the lives of the billions of people that suffer directly and indirectly from mental health disorders.